GlibenclamideHypoglycaemia following an off label treatment: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1708卷 / 1期

关键词：

D O I：

10.1007/s40278-018-48254-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：161 / 161

相关论文

共 50 条

[1] GlibenclamideHypoglycaemia following off-label use: case report
[J]. Reactions Weekly, 2021, 1857 (1) : 162 - 162
[2] GlibenclamideHypoglycaemia following an off-label use : case report
[J]. Reactions Weekly, 2021, 1866 (1) : 190 - 190
[3] OxaliplatinFever following off label treatment: case report
[J]. Reactions Weekly, 2022, 1898 (1) : 317 - 317
[4] GlibenclamideHypoglycaemia and treatment failure: case report
[J]. Reactions Weekly, 2021, 1863 (1) : 171 - 171
[5] PapaverinePostoperative haemorrhage following off label treatment: case report
[J]. Reactions Weekly, 2023, 1982 (1) : 344 - 344
[6] HydroxychloroquineHepatotoxicity following off-label treatment: case report
[J]. Reactions Weekly, 2020, 1812 (1) : 148 - 148
[7] PembrolizumabNeutropenia following off-label treatment: case report
[J]. Reactions Weekly, 2021, 1851 (1) : 288 - 288
[8] RivoceranibHaemafecia following off-label treatment: case report
[J]. Reactions Weekly, 2018, 1721 (1) : 263 - 263
[9] BupropionQTc Prolongation following off label treatment: case report
[J]. Reactions Weekly, 2022, 1894 (1) : 84 - 84
[10] BexaroteneTransaminitis following an off-label treatment: case report
[J]. Reactions Weekly, 2019, 1741 (1) : 59 - 59

← 1 2 3 4 5 →